Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis

NCT01265602 is registered in ClinicalTrials.gov with Almirall, S.A. as lead sponsor.

NCT NCT01265602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01265602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized, Vehicle- and Comparator-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of LAS41007 in the Treatment of Actinic Keratosis
Lead sponsor
Almirall, S.A.
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2010
Completion date
March 31, 2012
Enrollment
889 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis